Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.2 (
focal adhesion kinase
)
44,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The thymic stroma plays a critical role in the generation of T lymphocytes by direct cell-to-cell contacts as well as by secreting growth factors or hormones. The thymic epithelial cells, responsible for thymic hormone secretion, include morphologically and antigenically distinct subpopulations that may exert different roles in thymocyte maturation. The recent development of thymic epithelial cell lines provided an interesting model for studying thymic epithelial influences on T cell differentiation. Treating mouse thymocytes by supernatants from one of
TEC
line (IT-76M1), we observed an induction of thymocyte proliferation and an increase in the percentages of CD4-/CD8- thymocytes. This proliferation was largely inhibited when thymocytes were incubated with IT-76M1 supernatants together with an anti-thymulin monoclonal antibody, but could be enhanced by pretreating growing epithelial cells by triiodothyronine. We suggest that among the target cells for thymulin within the thymus, some putative precursors of early phenotype might be included.
...
PMID:Induction of thymocyte proliferation by supernatants from a mouse thymic epithelial cell line. 190 86
In 1986 and 1987 11 children with
TEC
(transient erythroblastopenia of childhood) were referred to our hospital. Bone marrow aspirations were performed to exclude haematological malignancy. There was a marked reduction of erythropoiesis in 9 cases (1%-8%), two children had already recovered (33% and 44% erythropoiesis). Eight patients exhibited high percentages of stimulated lymphoid cells. The subsequent immunotyping revealed the expression of CALLA (common acute lymphoblastic leukaemia antigen) on these cells but there was no other sign for malignancy. The patients recovered without any specific treatment except transfusions of packed red cells. Eight patients were followed up 11-18 months after initial presentation and were all found to be in good health. A prominent increase of CALLA-positive stimulated lymphoid cells has also been found in other haematological diseases such as neutropenia and immune thrombocytopenia. The expression of CALLA in bone marrow lymphocytes is a general reactive change to various alterations.
...
PMID:Increase of CALLA-positive stimulated lymphoid cells in transient erythroblastopenia of childhood. 214 Jul 75
Red blood cell aplasia in pediatric patients who have chronic hemolysis is associated most frequently with B19 infection. Although this entity is usually recognized easily, other red cell hypoplastic anemias, such as
TEC
and Diamond-Blackfan anemia, must be considered as part of the differential diagnosis. Although usually a transient event, an aplastic crisis has the potential for significant morbidity. The patient usually can be supported through the episode without incident with the judicious use of erythrocyte transfusions. The recognition of the infectious nature of the event is important for an understanding of the clinical manifestation, course of illness, and need for isolation. Several questions remain unanswered regarding the pathogenesis and treatment of this disorder. Could the use of intravenous gamma-globulin prove effective in treating select cases of B19-induced red cell aplasia? Are there effective measures to prevent B19 infection in children at risk for significant morbidity from such infection? There is interest in development of a vaccine to B19, and children with hereditary hemolytic anemias represent a potential target group for its use. Are there other viruses that cause red cell aplasia, especially in the case of TEC? It is hoped that current research will provide the answers for more effective treatment and possible prevention of these aplastic crises.
...
PMID:Aplastic crisis. 228 14
The Oxoid Signal (Oxoid U.S.A. Inc., Columbia, Maryland) system was compared with the nonradiometric BACTEC NR-660 (Johnston Laboratories, Towson, Maryland) system for detection of bacteria in 2714 blood cultures. The volume of blood collected into 20 ml blood-collection tubes containing sodium polyanetholsulfonate (SPS) (Becton Dickinson, Vacutainer Systems, Rutherford, New Jersey) ranged from 10 to 20 ml with an average of 15 ml. Subsequently, equal volumes of blood were inoculated into each system. A total of 250 organisms was isolated (9.6%), of which 149 (5.5%) were considered significant while 111 isolates from 98 cultures (3.6%) were contaminants. Of the significant isolates 32.9% were aerobic Gram-negative rods, 53.0% aerobic Gram-positive cocci, 5.4% anaerobes, 7.4% yeasts, and two isolates of Neisseria meningitidis. Ninety-five isolates were recovered in both systems, 29 by Bactec only and 25 by Signal only. Of the isolates recovered there were no significant differences in detection between the two systems with the exception of anaerobes (p less than 0.005). The median detection times for many of the most commonly isolated organisms--Enterobacteriaceae, streptococci, and Staphylococcus aureus--were very similar in both systems, ranging from 14 to 21 hours. With the remaining organisms recovered, the median times in hours for BAC-
TEC
and Signal, respectively, were 31 and 47 for Staphylococcus epidermidis, 48 and 60 for Bacteroides, 39 and 168 for yeast, and 16.5 and 168 for N. meningitidis. Oxoid Signal compares favorably with the BACTEC system. Its main advantages are: (1) it requires no instrumentation; (2) it is characterized by ease of detection; and (3) it uses a single-bottle system.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:A comparison of oxoid signal with nonradiometric BACTEC NR-660 for detection of bacteremia. 233 47
Embryonal carcinoma cells defective in the expression of developmentally regulated carbohydrate epitope of teratocarcinoma cells (
TEC
-1) were isolated from mutagenized P19X1 and P19S1801A1 cells by a single-step selection technique using monoclonal antibody
TEC
-01 conjugated to plant toxin ricin. Three independently isolated mutant cell lines were characterized in detail. Analysis of the expression of the
TEC
-1 epitope in somatic cell hybrids constructed between wild-type and mutant cells and between two mutant cell types revealed that the mutant phenotypes are recessive and that the mutants belong to, at least, two complementation groups. Each mutant cell line exhibited a unique binding pattern of four monoclonal antibodies and five lectins, and different properties of large glycopeptides were distinguished by Sephadex G-50 column chromatography. The combined data suggest that our mutants identify three genes involved in the synthesis of embryoglycan, one of which appears to be the regulatory or structural gene for fucosyltransferase. One mutant cell line was completely deprived of embryoglycan and several carbohydrate structures typical of early embryonic and embryonal carcinoma cells; however, the cells were similar to parental cells in their morphology, their ability to form aggregates when cultured in suspension, their ability to differentiate into neuron-like cells after treatment with retinoic acid, and their ability to form tumors composed of embryonal carcinoma cells. Thus, embryoglycan is not required for the expression of a number of properties of the embryonal carcinoma phenotype.
...
PMID:Mutants of embryonal carcinoma cells defective in the expression of embryoglycan. 244 94
The expression and properties of mouse embryonic antigens, recognized by monoclonal antibody
TEC
-02, were analyzed in teratocarcinoma-derived cell lines.
TEC
-2 antigens were found in the majority of the parietal endoderm cells PYS-2 and in a fraction of cultured embryonal carcinoma cells but not in other cell lines tested. During the course of retinoic acid-induced differentiation of embryonal carcinoma cells F9, the expression of
TEC
-2 was transiently increased. Immunolabeling of extracts from F9 and PYS-2 cells separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that
TEC
-2 antigens are polydisperse glycoconjugates of high molecular weight (mostly greater than 100,000). The
TEC
-2 epitope was shown to be carbohydrate which in F9 cells might be attached to the same carrier as another developmentally regulated carbohydrate epitope
TEC
-1. The
TEC
-2 antigens, isolated by indirect immunoprecipitation, were degraded by extensive pronase digestion or mild alkaline treatment to mostly large products. Immunostaining of glycolipid standards suggested that
TEC
-2 epitope involves the GalNAc beta 1----4Gal beta 1----4R sequence. Combined data indicate that
TEC
-2 is a new developmentally regulated carbohydrate epitope carried in embryonal carcinoma cells predominantly on glycoprotein-bound large carbohydrates.
...
PMID:The epitope of mouse embryonic antigen(s) recognized by monoclonal antibody TEC-02 is a carbohydrate carried by high-molecular-weight glycoconjugates. 244 54
Monoclonal antibody
TEC
-02, raised against mouse embryonal carcinoma cells, has been shown to react with murine preimplantation embryos and with a very limited number of adult mouse tissues. The target epitope,
TEC
-2, is a carbohydrate carried in mouse embryonal carcinoma cells by large glycoprotein-bound glycan. We report here the expression of
TEC
-2 epitope on human carcinoma-derived cell lines, HeLa and HS, and the properties of its carbohydrate carriers. Immunolabeling of Nonidet P-40 lysates of HeLa cells separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that
TEC
-2 antigens are polydispersed glycoconjugates of high molecular weight (mostly above 100,000).
TEC
-2 antigens detected by the two-site sandwich assay, in which the antigen is immobilized and detected with the same antibody, had a slightly higher molecular weight than those detected by the solid-phase assay. This suggests heterogeneity in the number of
TEC
-2 epitopes per carrier molecule. When the cells were lysed by Triton X-114 and the detergent and aqueous phases were separated by warming and centrifugation, most of the
TEC
-2 antigenic activity was found in the aqueous phase.
TEC
-2 antigens isolated by indirect precipitation from [3H]galactose-labeled HeLa cells were degraded by extensive pronase digestion or mild alkaline treatment to glycopeptides or oligosaccharides of low molecular weight. Thus,
TEC
-2 epitope in human HeLa cells is carried by carbohydrates of only several monosaccharide units.
TEC
-02 antibody was also found to bind to Tamm-Horsfall glycoprotein isolated from human urine and its binding was enhanced by desialylation. Combined data indicate that
TEC
-02 antibody recognizes the GalNAc beta 1----4Gal beta 1----4 structure which may be carried on different types of molecule, according to the site of their synthesis.
...
PMID:Expression of mouse embryonic epitope TEC-2 on human carcinoma-derived cell lines and characterization of its glycoprotein carriers. 244 11
Embryonal carcinoma cells carry on their surfaces carbohydrate antigens that are also expressed in early embryonic cells. We report here the expression and properties of a new developmentally regulated carbohydrate epitope, which is defined by a monoclonal antibody
TEC
-05. This antibody was generated by immunization of a rat with mouse embryonal carcinoma cells P19S1801A1. By immunofluorescence, the
TEC
-5 epitope was first detected on 8-cell-stage mouse embryos and was present on all subsequent stages of preimplantation development. Absorption analysis revealed that
TEC
-5 epitope was expressed only on a limited number of adult mouse tissues. In the direct radioantibody binding assay,
TEC
-05 reacted strongly with OTF9-63 cells and with some of the mouse embryonal carcinoma cell lines tested. Its reaction with differentiated cell lines was weak or undetectable. In the course of differentiation of OTF9-63 cells induced by retinoic acid, the epitope disappeared with the onset of morphological differentiation. The binding of the antibody to OTF9-63 cells was inhibited to 50% by 10-50 microM N-acetyllactosamine and lactose. Immunolabelling of extracts from OTF9-63 cells separated by sodium-dodecyl-sulfate (SDS) polyacrylamide gel electrophoresis revealed that
TEC
-5 epitope was carried by high-molecular-weight glycoconjugates (molecular weight greater than 100,000). Molecules, isolated from [3H]-fucose-labelled OTF9-63 cells by indirect immunoprecipitation with
TEC
-05 antibody, were degraded by extensive pronase digestion or mild alkaline treatment to large carbohydrate chains that were excluded from a Sephadex G-50 column. Direct evidence that
TEC
-05 antibody bound to embryoglycan was obtained using a modified Farr's assay. The antibody was found to inhibit adhesion of F9 and OTF9-63 cells to substratum. The inhibitory effect, which could be abrogated by lactose, seemed to be specific, because another IgM monoclonal antibody which also binds to embryoglycan had no effect. Combined data indicated that
TEC
-05 antibody recognizes a carbohydrate epitope which is involved in cell-substratum adhesion of F9 cells and which provides a new marker for structure-function studies of stage-specific embryonic antigens.
...
PMID:Inhibition of adhesion of F9 embryonal carcinoma cells to substratum by a novel monoclonal antibody, TEC-05, reactive with a developmentally regulated carbohydrate epitope. 245 92
Immunohistochemical characterization of rat
TEC
has been studied using a panel of monoclonal anti-keratin antibodies. These mAbs identified three distinct patterns of keratin subunit expression within thymic epithelium assessed by streptavidin-biotin immunoperoxidase staining and double immunofluorescence staining. K8 and KII mAbs labelled almost all epithelium, while K18 stained cortical epithelium and a subpopulation of medullary
TEC
. KI, K7 and K19 mAbs bound to the subcapsular/subtrabecular flat epithelial cell layer,
TEC
lining some perivascular spaces in the cortex, a subpopulation of medullary
TEC
and interstitial epithelial cystic structures. Double immunostaining revealed further heterogeneity of subunit keratin compositions in epithelial cells of particular thymic microenvironments suggesting their different origin or development stage.
...
PMID:Heterogeneity of rat thymic epithelium defined by monoclonal anti-keratin antibodies. 247 1
Antibodies against thymus epithelial cells (anti-TEC) and the basal cell layer (BCLA) of squamous epithelia have been described in association with HDV-related chronic liver disease (CLD). Data are lacking on their presence during nAnB virus infection. Sera from 51 patients with nAnB post-transfusion hepatitis, including acute and chronic cases diagnosed during a prospective study on candidates for cardiac surgery, and 167 with various forms of CLD were tested for the presence of anti-
TEC
and BCLA using indirect immunofluorescence on human thymus and rat forestomach sections. Both antibodies mainly occurred in nAnB, HDV and cryptogenic CLD (anti-TEC: 51%, 47% and 42%; BCLA: 29%, 38% and 31%, respectively). The prevalence of anti-
TEC
in nAnB CLD turned out to be higher than that recorded in alcoholic, HBV-related, autoimmune, liver and kidney microsomal antibody positive CLD and primary biliary cirrhosis (p ranging from less than 0.03 to less than 0.0004). Two monoclonal antibodies (Mabs) to cytokeratins gave a pattern superimposable on that of spontaneous anti-
TEC
(both Mabs) and BCLA (only one). Antibodies against epithelial constituents, presumably targeting cytokeratin-associated antigens, occur not only in HDV CLD, as previously reported, but also in nAnB CLD, where they might represent a diagnostic aid, due to the unavailability of reliable serological markers of nAnB infection. The close similarity of anti-
TEC
and BCLA status between nAnB and cryptogenic CLD suggests a nAnB etiology of at least a proportion of chronic liver patients at present scored as cryptogenic.
...
PMID:Serum antibodies to thymus epithelial cells in non-A, non-B and cryptogenic chronic liver disease. 247 4
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>